达格列净联合利尿剂对2型糖尿病合并慢性心力衰竭患者尿酸水平与预后的影响OA
Effects of Dapagliflozin Combined with Diuretics on Uric Acid and Prognosis in Patients with Type 2 Diabetes Mellitus and Chronic Heart Failure
目的:探讨达格列净联合利尿剂对2型糖尿病合并慢性心力衰竭(CHF)患者尿酸(UA)水平及预后的影响.方法:前瞻性选取2019年6月~2024年6月在某院诊治的104例 2 型糖尿病合并 CHF 患者,采用随机数字表法分为对照组(利尿剂治疗)和研究组(达格列净联合利尿剂治疗),每组 52 例.比较两组患者血糖、心功能、肾功能、临床疗效、不良反应及预后情况.结果:治疗3 个月后,两组患者空腹血糖(FBG)、餐后 2 h 血糖(2hPG)、糖化血红蛋白(HbA1c)、平均血糖波动(MAGE)、最大血糖波动(LAGE)、血糖变异系数(GlucV)、左心室质量指数(LVMI)、左心室重构指数(LVRI)、N端脑钠肽前体(NT-proBNP)、脑钠肽(BNP)、UA、血尿素氮(BUN)、血肌酐(SCr)均降低(P<0.05),且研究组低于对照组(P<0.05);心脏指数(CI)、左心室射血分数(LVEF)、肾小球滤过率(GFR)均升高(P<0.05),且研究组高于对照组(P<0.05).研究组临床治疗总有效率(94.23%)高于对照组(80.77%,P<0.05).两组患者不良反应总发生率比较无统计学差异(P>0.05).研究组主要不良心血管事件、因CHF再入院的发生率低于对照组(3.85%vs 17.31%,1.92%vs 13.46%,P<0.05).结论:达格列净联合利尿剂治疗 2 型糖尿病合并 CHF 患者疗效良好,可更有效地控制血糖波动、改善心功能指标、降低 UA 水平并保护肾功能,改善预后,且未增加不良反应发生风险.
Objective:To dapagliflozin combined with diuretics on serum uric acid(UA)levels and prognosis in patients with type 2 diabetes mellitus(T2DM)complicated by chronic heart failure(CHF).Methods:In this prospective study,104 patients with T2DM complicated by CHF who were treated at a hospital between June 2019 and June 2024 were selected and randomly assigned by a random number table method to a control group(diuretics alone)and a study group(dapagliflozin combined with diuretics),with 52 cases in each group.Blood glucose,cardiac function,renal function,clinical efficacy,adverse reactions,and prognosis were compared between the two groups.Results:After 3 months of treatment,fasting blood glucose(FBG),2-h postprandial blood glucose(2hPG),glycated hemoglobin(HbA1c),mean amplitude of glycemic excursions(MAGE),largest amplitude of glycemic excursions(LAGE),glucose coefficient of variation(GlucV),left ventricular mass index(LVMI),left ventricular remodeling index(LVRI),N-terminal pro-B-type natriuretic peptide(NT-proBNP),brain natriuretic peptide(BNP),UA,blood urea nitrogen(BUN),and serum creatinine(SCr)decreased in both groups(P<0.05),and these indices were lower in the study group than in the control group(P<0.05).Cardiac index(CI),left ventricular ejection fraction(LVEF),and glomerular filtration rate(GFR)increased in both groups(P<0.05)and were higher in the study group than in the control group(P<0.05).The overall response rate was higher in the study group than in the control group(94.23%vs.80.77%,P<0.05).No significant difference was observed in the overall incidence of adverse reactions between the two groups(P>0.05).The incidences of major adverse cardiovascular events(MACE)and readmission due to CHF were lower in the study group than in the control group(3.85%vs.17.31%and 1.92%vs.13.46%,P<0.05).Conclusion:Dapagliflozin combined with diuretics are effective in patients with T2DM complicated by CHF.This regimen can more effectively control glycemic fluctuation,improve cardiac function,reduce UA levels,protect renal function,and improve prognosis without increasing the overall risk of adverse reactions.
王朝旭;刘明明;沈亚非;谢亚争;吴丹;王丹萍
漯河市中心医院(漯河市第一人民医院)内分泌科,漯河 462000漯河市中心医院(漯河市第一人民医院)心血管内科,漯河 462000漯河市中心医院(漯河市第一人民医院)内分泌科,漯河 462000漯河市中心医院(漯河市第一人民医院)内分泌科,漯河 462000漯河市中心医院(漯河市第一人民医院)内分泌科,漯河 462000漯河市中心医院(漯河市第一人民医院)内分泌科,漯河 462000
医药卫生
达格列净利尿剂2型糖尿病慢性心力衰竭尿酸预后
dapagliflozindiureticstype 2 diabetes mellituschronic heart failureuric acidprognosis
《中国合理用药探索》 2026 (3)
56-62,7
河南省二〇二一年科技发展计划(212102310798)
评论